Photo above: Gaby Waisman (left) and Eitan Oppenhaim
Gaby Waisman, who has served as the Nova’s Chief Business Officer since 2016, has been appointed as CEO and President. Eitan Oppenhaim, Nova’s CEO and President since 2013, has been appointed as Executive Chairman of the Board, succeeding Micha Brunstein. The changes will be effective March 31, 2023. Waisman He oversaw the Company’s business units, global branches, sales, application and service teams. . He is a seasoned leader with more than 20 years of proven management roles in global public companies.
During Oppenhaim’s tenure as CEO, Nova accelerated its growth while strengthening the company’s position across industry segments, territories, and customers. He was also responsible for the successful acquisitions of ReVera and ancosys as part of the Nova’s long-term strategy to diversify its activities. “I am pleased to announce Gaby’s appointment as Nova’s CEO and President,” said Avi Cohen, Nova Interim Chairman of the Board. “Gaby’s appointment reflects the Board’s well-established and thoughtful succession plan.”
Rehovot (Israel) based Nova provides material, optical and chemical metrology solutions for advanced process control in semiconductor manufacturing. Its main competitors are Onto Innovation (formerly Nanometrics and Rudolph Technologies, who have merged in 2019), KLA which manufacture and sell process control systems and process equipment manufacturers such as ASML and Applied Materials. Nova’s total revenues for 2022 were $570.7 million, an increase of 37% compared to total revenues of $416.1 million for 2021.